202
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Characterization of the antigenicity of Cpl1, a surface protein of Cryptococcus neoformans var. neoformans

, , , , , , , , & show all
Pages 39-45 | Received 24 Mar 2014, Accepted 05 Aug 2014, Published online: 20 Jan 2017

Literature cited

  • BlevinsLBFennJSegalHNewcomb-GaymanPCarrollKC. 1995. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 33:1674–1675.
  • BrandtMEBraggSLPinnerRW. 1993. Multilocus enzyme typing of Cryptococcus neoformans. J Clin Microbiol 31: 2819–2823.
  • BulmerGSSansMDGunnCM. 1967. Cryptococcus neoformans I. Nonencapsulated mutants. J Bacteriol 94:1475–1479.
  • ChanJFTengJLLiIWWongSCLeungSSHoPOToKKLauSKWooPCYuenKY. 2014. Fatal empyema thoracis caused by Schizophyllum commune with cross reactive cryptococcal antigenemia. J Clin Microbiol 52: 683–687, doi:10.1128/JCM.02770-13
  • ChaturvediVChaturvediS. 2011. Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol 19:564–571, doi:10.1016/j.tim.2011.07.010
  • ChimCSLiangRWongSSYuenKY. 2000. Cryptococcal infection associated with fludarabine therapy. Am J Med 108:523–524, doi:10.1016/S0002-9343(99)00428-3
  • DalyRHearnMT. 2005. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 18:119–138, doi:10.1002/jmr.687
  • GasteigerEHooglandCGattikerADuvaudSWilkinsMRAppelRDBairochA. 2005. Protein identification and analysis tools on the ExPASy server. WalkerJohn M, ed. Humana Press: The proteomics protocols handbook. p 571–607.
  • HaoWPanYXDingYQXiaoSYinKWangYDQiuLWZhangQLWooPCLauSKet al. 2008. Well characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity. Clin Vaccine Immunol 15: 194–202, doi:10.1128/CVI.00362-07
  • KontoyiannisDP. 2003. What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients? Mycoses 46:161–163, doi:10.1046/j.1439-0507.2003.00877.x
  • KozelTRLevitzSMDromerFGatesMAThorkildsonPJanbonG. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect Immun 71:2868–2875, doi:10.1128/IAI.71.5.2868-2875.2003
  • LiuOWChunCDChowEDChenCMadhaniHDNobleSM. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174–188, doi:10.1016/j.cell.2008.07.046
  • McManusEJJonesJM. 1985. Detection of a Trichosporon beigelii antigen cross reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 21:681–685.
  • MokCCLauCSYuenKY. 1998. Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 16:169–171.
  • NakaiKHortonP. 1999. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 24:34–36, doi:10.1016/S0968-0004(98)01336-X
  • O’MearaTRAlspaughJA. 2012. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev 25:387–408, doi:10.1128/CMR.00001-12
  • PercivalAThorkildsonPKozelTR. 2011. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Clin Vaccine Immunol 18:1292–1296, doi:10.1128/CVI.05052-11
  • PetersenTNBrunakSvon HeijneGNielsenH. 2011. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8:785–786, doi:10.1038/nmeth.1701
  • SahaDCXessIBiswasABhowmikDMPadmaMV. 2009. Detection of Cryptococcus by conventional, serological and molecular methods. J Med Microbiol 58:1098–1105, doi:10.1099/jmm.0.007328-0
  • StammAMPoltSS. 1980. False-negative cryptococcal antigen test. JAMA 244:1359, doi:10.1001/jama.1980.03310120047024
  • SteentoftCVakhrushevSYJoshiHJKongYVester-ChristensenMBSchjoldagerKTLavrsenKDabelsteenSPedersenNBMarcos-SilvaLet al. 2013. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J 32: 1478–1488, doi:10.1038/emboj.2013.79
  • ToKKChengVCTangBSFanYWYuenKY. 2006. False-negative cerebrospinal fluid cryptococcal antigen test due to small-colony variants of Cryptococcus neoformans meningitis in a patient with cystopleural shunt. Scand J Infect Dis 38:1110–1114, doi:10.1080/00365540600664118
  • VersalovicJ, ed. 2011. Manual of clinical microbiology. Washington: ASM Press. 2630 p.
  • WangYFCaiJPWangYDDongHHaoWJiangLXLongJChanCWooPCLauSKet al. 2011. Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis. PLoS One 6:e28796, doi:10.1371/journal.pone.0028796
  • WangZYCaiJPQiuLWHaoWPanYXTungETLauCCWooPCLauSKYuenKYet al. 2012. Development of monoclonal antibody-based galactomannoprotein antigen-capture ELISAs to detect Aspergillus fumigatus infection in the invasive aspergillosis rabbit models. Eur J Clin Microbiol Infect Dis 31:2943–2950, doi:10.1007/s10096-012-1645-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.